ERBB2 and breast carcinoma: Human breast cancer includes a highly diverse set of diseases, and is classified into at least 6 distinct clinically-relevant molecular subgroups - luminal A, luminal B, HER2+/ER-, basal-like, normal breast-like, and the most recently recognized claudin-low23, 24.